HSY
38
-7
SHW
53
-2
MAT
43
2
MU
42
7
PEP
41
-6
RRC
63
8
PDCO
75
10
HAL
41
2
HRL
50
-3
LEG
36
5
URBN
70
-2
WU
30
-2
LRCX
65
6
PSA
51
-2
DTE
47
-2
DOW
36
-2
PH
66
2
GLW
41
-4
XRAY
50
4
SJM
21
-3
HSY
38
-7
SHW
53
-2
MAT
43
2
MU
42
7
PEP
41
-6
RRC
63
8
PDCO
75
10
HAL
41
2
HRL
50
-3
LEG
36
5
URBN
70
-2
WU
30
-2
LRCX
65
6
PSA
51
-2
DTE
47
-2
DOW
36
-2
PH
66
2
GLW
41
-4
XRAY
50
4
SJM
21
-3
Financhill
Back

Replimune Group 10K Form

Sell
29

REPL
Replimune Group

Last Price:
12.65
Seasonality Move:
-15.42%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive REPL News And Ratings

See the #1 stock for the next 7 days that we like better than REPL

REPL Financial Statistics

Sales & Book Value

Annual Sales: $4.95K
Cash Flow: $-40.72M
Price / Cash Flow: 0
Annual Sales: $5.58
Price / Book: 2.3

Profitability

EPS (TTM): -3.05000
Net Income (TTM): $-213.02M
Gross Margin: $4.95K
Return on Equity: 0%
Return on Assets: 0%

Replimune Group Earnings Forecast

Key Replimune Group Financial Ratios

  • The Gross Profit Margin over the past 1 years for REPL is 100.00%.
  • The Selling, General & Administrative Expenses for REPL have been equal to 1,021,272.73% of Gross Profit Margin.
  • The Interest Expense is -3.09% of Operating Income.
  • Per Share Earnings over the last 8 years have been positive in 1 years.

Replimune Group Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: REPL
CUSIP: 76029N
Website: replimune.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 0
Quick Ratio: 0

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

REPL Technical Analysis vs Fundamental Analysis

Sell
29
Replimune Group (REPL) is a Sell

Is Replimune Group a Buy or a Sell?

  • Replimune Group stock is rated a Sell
    The current Replimune Group [REPL] share price is $12.64. The Score for REPL is 29, which is 42% below its historic median score of 50, and infers higher risk than normal.